MeSH Terms
Antibodies, Monoclonal, Humanized/adverse effects,therapeutic use
Antineoplastic Agents, Immunological/adverse effects,therapeutic use
Female
Humans
Liver Neoplasms/drug therapy,secondary
Melanoma/drug therapy,pathology
Middle Aged
Peripheral Nervous System Diseases/chemically induced
Vasculitis/chemically induced
Chemicals
Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
pembrolizumab
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Aya F
Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Spain | Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain.
Ruiz-Esquide V
Arthritis Unit, Rheumatology Department, Hospital Clínic, IDIBAPS, Villarroel, 170, 08036 Barcelona, Spain.
Viladot M
Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Spain
Font C
Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Spain
Prieto-González S
Systemic Autoimmune Diseases, Vasculitis Research Unit, Hospital Clinic Barcelona.
Prat A
Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Spain | Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Arance A
Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Spain | Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.